Medicinal Mushrooms Proving to Eradicate Human Papillomavirus

Medicinal Mushrooms Proving to Eradicate Human Papillomavirus

Medicinal Mushrooms


Multiple studies are showing that medicinal mushrooms can treat and eradicate Human Papillomavirus (HPV) infections, which can lead to cervical cancer.

French Study Treating HPV With Reishi and Trametes

Research from France's Medicine Information Formation conducted a study of 472 gingivitis patients who were swabbed and screened for HPV. They found that 61 of the patients were positive for either HPV16 or HPV18.


The researchers then randomized the HPV-positive patients and for two months the researchers treated 20 patients with the medicinal mushroom species Laetiporus sulphureus. The other 41 patients were treated with a combination of Trametes versicolor and Ganoderma lucidum.


After the two months, the researchers found that 88% of the 41 patients treated with Trametes versicolor and Ganoderma lucidum tested negative for HPV. In the other group, 5% tested negative for HPV.

U.S. Research Using Mycelia Extract on HPV

On the heels of this study comes research from the University of Texas Medical School and the UT Health Science Center. A series of studies – a small human study preceded by a study on mice – has shown that a medicinal mushroom extract called AHCC is effective in eradicating human papillomavirus (HPV).


The results of this study were presented at the 11th International Conference of the Society for Integrative Oncology in Houston on October 28, 2014.


In the study, ten women who tested positive for HPV were treated with the mushroom mycelia extract called AHCC.  AHCC stands for active hexose correlated compound. It is an extract from the mycelia of Shiitake mushroom (Lentinula edodes) along with other medicinal mushrooms. The mycelia is the root-like fingers that weave within the growing medium – whether soil or in the case of AHCC cultivation, within rice bran.


The patients were given three grams (3,000 mg) of the AHCC once a day for at least six months. During that period, eight of the patients tested negative for HPV, including three that were confirmed eradicated after stopping the AHCC treatment.

The other two patients are continuing the treatment.


The research, led by Dr. Judith Smith, a professor at the UTHealth Medical School, is now going to proceed to a Phase II clinical trial. Dr. Smith stated in a press release from the University of Texas:

"We were able to determine that at least three months of treatment is necessary but some need to extend that to six months. Since AHCC is a nutritional supplement with no side effects and other immune modulating benefits, we will be planning on using six months of treatment in our phase II clinical study to have consistent study treatment plan. This confirms our earlier preclinical research."

Preclinical Research Supported Eradication Hypothesis

The preclinical research Dr. Smith refers to is a study done on in vitro cells and mice. The researchers gave 50 milligrams per kilogram of the AHCC to mice with HPV16/18 for 90 days with 30 days of follow up, and compared to untreated mice.

This study found that for the cell treatments, seven days of AHCC treatment followed by seven days of no treatment resulted in eradication of the HPV. In the mice, 90 days of treatment with 30 days of no treatment resulted in eradication of the HPV. In mice treated with tumors, significant tumor suppression was found.

Continue to Page 2

Pages :
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.

Popular Threads

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2016, Journal Articles copyright of original owners, MeSH copyright NLM.